Biosimilars: Global Markets

Report Code: BIO090E

Publish Date: Mar 2025

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

30% Off

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.

Report Includes

  • 142 data tables and 74 additional tables
  • An analysis of the global market trends for biosimilars, with historic revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects, along with a market share analysis by product type and sub-type, therapeutic application, and region
  • Facts and figures pertaining to the market dynamics, advances in existing biosimilars, regulations and the impact of macroeconomic factors
  • Review of the industry structure, emerging trends and developments, clinical trials and approvals, and new product
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • An analysis of key patent publications, grants and applications in biosimilars
  • Analysis of the competitive landscape featuring companies’ market shares, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
  • Profiles of the market leaders, including Amgen Inc., Sandoz Group AG, Biocon Biologics Ltd., Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Report Scope

This report provides the current and future market potential of biosimilars, with market projections through 2029; and it includes a detailed analysis of the drivers, restraints and opportunities in the biosimilars market. The report also covers the competitive environment of the biosimilars industry and features a product analysis.

For this analysis, the market for biosimilars is segmented based on product type, therapeutic application and region. Based on product type, it is segmented into monoclonal antibodies, recombinant growth factors, recombinant hormones, fusion protein and others (such as LMWHs and interferons). Based on therapeutic application, the market is segmented into the following: cancer and related disorders, autoimmune and inflammatory diseases, diabetes, anemia, growth hormone deficiency and other diseases. Based on geographical region, the biosimilars market is segmented into the following: North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimate data, 2021 and 2022 serve as the historical years, 2023 as the base year, and 2029 as the forecast year.

The report provides company profiles of key players in the biosimilars market that feature detailed information about each organization’s business segments, financials, product portfolios and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $23.8 Billion
Market size forecast $69.2 Billion
Growth rate CAGR of 19.4% from 2024 to 2029
Units considered $ Millions
Segments covered Product Type, Therapeutic Application, and Region
Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Countries covered The U.S., Canada, Mexico, Italy, Spain, Germany, the U.K., France, Japan, China, India, Australia and South Korea
Key Market Drivers
  • Patent expirations of major biologics.
  • Cost-effectiveness and healthcare savings.
  • Increasing access to and adoption and awareness of biosimilar drugs.
Companies studied
ACCORD BIOPHARMA INC.ALVOTECH
AMGEN INC.AMNEAL PHARMACEUTICALS LLC.
BIOCON BIOLOGICS LTD.BIOGEN
CELLTRION INC.COHERUS BIOSCIENCES
FRESENIUS KABI AGLILLY
PFIZER INC.SAMSUNG BIOEPIS
SANDOZ GROUP AGTEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The biosimilars market is projected to grow from $23.8 billion in 2023 to $69.2 billion in 2029 at a compound annual growth rate (CAGR) of 18.6% during the forecast period.
Patent expirations of major biologics and cost-effectiveness and healthcare savings are driving the market growth.
The market is segmented by product type, therapeutic application, and region.
Monoclonal antibodies segment will dominate the market by the end of 2029.
Pfizer Inc., Sandoz Group AG, Amgen Inc., Biogen, Samsung Bioepis, Biocon, and Teva Pharmaceutical Industries Ltd.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biosimilars: Global Markets219Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview26Free
Chapter- 3: Market Dynamics6Free
Chapter- 4: Emerging Technologies2Free
Chapter- 5: Market Segmentation Analysis117Free
Chapter- 6: Competitive Landscape and Patent Analysis6Free
Chapter- 7: Regulatory Aspects4Free
Chapter- 8: Sustainability in the Global Biosimilars Market: An ESG Perspective5Free
Chapter- 9: Appendix49Free

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

2024 Protein Synthesis Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - BIO264A

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.

Intravenous (IV) Therapy and Vein Access: Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC046F

The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 216

  • Summary Table: Global Biosimilars Market, by Region, Through 2029
  • Table 1: Differences Between Generic and Biosimilar Drugs
  • Table 2: Terminology Related to Biosimilars
  • Table 3: Biosimilars Vs. Biobetters
  • Table 4: Examples of Approved Biobetters
  • Table 5: Representative Biobetters in Clinical Trials
  • Table 6: Key Developments in Biosimilar Recombinant Hormones
  • Table 7: Key Developments in Biosimilar Recombinant Growth Factors
  • Table 8: Key Developments in Biosimilar Monoclonal Antibodies
  • Table 9: Key Developments in Enbrel (Etanercept) Biosimilars
  • Table 10: Key Developments in Biosimilar Interferons
Sample Report

Recent Reports

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Jun-2021| Analyst - Kamna Jhamb| Code - BIO090D

Report Highlights

The global biosimilars market should reach $60.1 billion by 2025 from $15.7 billion in 2020 at a compound annual growth rate (CAGR) of 30.9% for the forecast period of 2020 to 2025.

Report Includes

  • 69 data tables and 73 additional tables
  • An updated review and industry insights of the global biosimilars market
  • Analyses of the global market trends, with data from 2018 to 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Highlights of the emerging market regulations, clinical trials, and new products launches; and their impact on the stakeholders in this market
  • Discussion of the biosimilars industry structure, opportunities and complexities, regulatory updates and penetration of biosimilar product classes in various regions worldwide
  • Estimation of current market size and potential growth forecast for biosimilars market, and corresponding market share analysis by product type, application/disease category and geographic region
  • A detailed review of patents issued for biosimilars by different assignee categories
  • Impact analysis of COVID-19 pandemic on the growth of biosimilars market as compared to overall pharmaceuticals industry with respect to clinical trials/approvals
  • Company profiles of the major market players, including Amgen Inc., Boehringer Ingelheim, Cipla Ltd., Dr Reddy’s Laboratories Ltd., Lupin Ltd., Pfizer Inc. and Zydus Cadila
Published - Apr-2018| Analyst - Kamna Jhamb| Code - BIO090C

Report Highlights

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Report Includes

  • 80 data tables and 16 additional tables
  • An overview of the global market for biosimilars
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A look at biosimilar product classes in various regions worldwide, as well as the worldwide pipeline for biosimilars
  • Detailed analysis of the emerging framework in regulated markets, as well as comparisons of biosimilar guidelines in Europe, the U.S., Japan, Canada, as well the guidelines developed by the World Health Organization
  • Technology trends and patent analyses
  • Comprehensive company profiles of key players in the market, including Allergan Plc., Bioton S.A., Cinnagen, Emcure Pharmaceuticals Ltd., LG Life Sciences, Neuclone and Pfizer Inc.
Published - Jan-2015| Analyst - Shalini Shahani Dewan| Code - BIO090B

Report Highlights

The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth rate (CAGR) of 15% from 2014 through 2019.

Report Includes

  • An overview of the global market for biosimilars.
  • Analyses of global market trends, with data from 2012 through 2014, and projections of CAGRs through 2019.
  • A look at biosimilar product classes in various regions worldwide, as well as the worldwide pipeline for biosimilars.
  • Detailed analysis of the emerging regulatory framework in regulated markets as well as comparisons of biosimilar guidelines in Europe, the U.S., Japan, Canada, and the guidelines developed by WHO.
  • Technology trends and patent analysis.
  • Comprehensive profiles of key players in the market.
Published - May-2012| Analyst - Syamala Ariyanchira| Code - BIO090A

Report Highlights

The global market for biosimilars reached $1.7 billion in 2010 and $2.5 billion in 2011. The market is expected to reach $3.6 billion by 2016, a compound annual growth rate (CAGR) of 7.7%.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biosimilars: Global Markets
Sample Report